AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

Những quyển sách tương tự

• BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
  Bằng: Bach, Duc-Hiep, et al.
  Được phát hành: (2018)
• Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells
  Bằng: Bach, Duc-Hiep, et al.
  Được phát hành: (2018)
• AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells
  Bằng: Choi, Yun Jung, et al.
  Được phát hành: (2015)
• Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
  Bằng: Kang, Da Hyun, et al.
  Được phát hành: (2020)
• Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
  Bằng: La Monica, Silvia, et al.
  Được phát hành: (2017)